Stability and compatibility of vancomycin for administration by continuous infusion

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 5, 2013, Pages 1179-1182

  Raverdy, Violeta ^a,c   Ampe, Els ^a,d   Hecq, Jean Daniel ^a,b   Tulkens, Paul M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^c UNIV LILLE   (France)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

lactams; European pharmacopoeia; Furosemide; Methylprednisolone; Phenytoin; Propofol; Theophylline; Valproic acid

Indexed keywords

ACETYLCYSTEINE; ADRENALIN; AMINOGLYCOSIDE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; DOBUTAMINE; DOPAMINE; FLUCLOXACILLIN; FUROSEMIDE; IMIPENEM; KETAMINE; MACROLIDE; METHYLPREDNISOLONE; MIDAZOLAM; MORPHINE; MOXIFLOXACIN; NICARDIPINE; PARACETAMOL; PHENYTOIN; PIPERACILLIN PLUS TAZOBACTAM; PIRITRAMIDE; PROPOFOL; SUFENTANIL; TEMOCILLIN; THEOPHYLLINE; UNINDEXED DRUG; URAPIDIL; VALPROIC ACID; VANCOMYCIN;

ARTICLE; BIOCOMPATIBILITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG STABILITY; DRUG STORAGE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH TEMPERATURE; STORAGE TEMPERATURE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG STABILITY; HUMANS; INFUSIONS, INTRAVENOUS; VANCOMYCIN;

EID: 84876282492     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks510     Document Type: Article

References (20)

1. Saugel B, Nowack MC, Hapfelmeier A et al. Continuous intravenous administration of vancomycin in medical intensive care unit patients. J Crit Care 2013; 28: 9-13.
2. Van Herendael B, Jeurissen A, Tulkens PM et al. Continuous infusion of antibiotics in the critically ill: the new holy grail for b-lactams and vancomycin? Ann Intensive Care 2012; 2: 22.
3. Cataldo MA, Tacconelli E, Grilli E et al. Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother 2012; 67: 17-24.
4. Hecq JD. Centralized intravenous additive services (CIVAS): the state of the art in 2010. Ann Pharm Fr 2011; 69: 30-7.
5. Nornoo AO, Elwell RJ. Stability of vancomycin in icodextrin peritoneal dialysis solution. Ann Pharmacother 2006; 40: 1950-4.
6. LaPlante KL, Woodmansee S, Mermel LA. Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions. Am J Health Syst Pharm 2012; 69: 1405-9.
7. Dotson B, Lynn S, Savakis K et al. Physical compatibility of 4% sodium citrate with selected antimicrobial agents. Am J Health Syst Pharm 2010; 67: 1195-8.
8. Pritts D, Hancock D. Incompatibility of ceftriaxone with vancomycin. Am J Hosp Pharm 1991; 48: 77.
9. Szof C, Walker PC. Incompatibility of cefotaxime sodium and vancomycin sulfate during Y-site administration. Am J Hosp Pharm 1993; 50: 2054, 2057.
10. Wazny LD, Blake PG. Incompatibility of vancomycin and ceftazidime for intraperitoneal use. Perit Dial Int 2002; 22: 93-4.
11. Galanti LM, Hecq JD, Vanbeckbergen D et al. Long-term stability of vancomycin hydrochloride in intravenous infusions. J Clin Pharm Ther 1997; 22: 353-6.
12. Trissel LA. Handbook on Injectable Drugs. Bethesda, MD: American Association of Hospital Pharmacists (ASHP), 2011.
13. Hecq JD. Stabilité des médicaments injectables en perfusion (CD-Rom edition). Brussels: Association belge des pharmaciens hospitaliers-Belgische Vereniging van Ziekenhuis Apothekers (ABPHBVZA), 2012.
14. Servais H, Tulkens PM. Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients. Antimicrob Agents Chemother 2001; 45: 2643-7.
15. Baririan N, Chanteux H, Viaene E et al. Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units. J Antimicrob Chemother 2003; 51: 651-8.
16. Berthoin K, Ampe E, Tulkens PM et al. Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections. Int J Antimicrob Agents 2009; 34: 555-60.
17. European Pharmacopoeia Online (European Directorate for the Quality of Medicines & Health Care, Council of Europe, Strasbourg, France). Vancomycin hydrochloride. http://online6.edqm.eu/ep705/ (6 November 2012, date last accessed).
18. Cairns CJ, Robertson J. Incompatibility of ceftazidime and vancomycin. Pharm J 1987; 238: 577.
19. Allen LV Jr, Stiles ML, Prince SJ et al. Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection. Am J Health Syst Pharm 1995; 52: 2427-33.
20. Trissel LA, Xu QA, Martinez JF. Compatibility and stability of aztreonam and vancomycin hydrochloride. Am J Health Syst Pharm 1995; 52: 2560-4.